Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children.
Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children. JAMA Otolaryngol Head Neck Surg. 2013 May; 139(5):496-501.
View in:
PubMed
subject areas
Adolescent
Age Factors
Biopsy, Needle
Chemotherapy, Adjuvant
Child
Child, Preschool
Cohort Studies
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Infant
Injections, Intralesional
Laryngeal Neoplasms
Laryngoscopy
Laser Therapy
Male
Neoplasm Invasiveness
Neoplasm Staging
Papillomavirus Infections
Pilot Projects
Prospective Studies
Quality of Life
Reoperation
Respiratory Tract Infections
Risk Assessment
Survival Analysis
Time Factors
Treatment Outcome
authors with profiles
Christopher J. Hartnick, M.D.
Rie Maurer, M.A.